AI & Machine Learning
How early efforts to build autonomous clinical AI tools are approaching regulation
Multiple teams participating in ARPA-H’s Advocate program have already had an initial informational meeting with the FDA, less than two months after the clinical AI initiative launched, ARPA-H program manager Haider Warraich said on Thursday. ...
Multiple teams participating in ARPA-H’s Advocate program have already had an initial informational meeting with the FDA, less than two months after the clinical AI initiative launched, ARPA-H program manager Haider Warraich said on Thursday. ...
This is a summary of the story. Read the full article at Endpoints News (Biopharma) ↗